CELL PLAZA Trademark

Trademark Overview


On Friday, December 21, 2012, a trademark application was filed for CELL PLAZA with the United States Patent and Trademark Office. The USPTO has given the CELL PLAZA trademark a serial number of 79129103. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, December 21, 2022. This trademark is owned by Genloci Biotechnologies Inc.. The CELL PLAZA trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; bacterial and bacteriological preparations for medical or veterinary purposes; pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, p...

Protein in raw material form for scientific and medical research; enzymes for the brewing industry; enzymes for use in the textile industry; enzymes for use in the dairy industry; enzymes for use in the food industry; stain repellents for textiles; industrial chemicals; biochemical catalysts; chemical preparations for scientific purposes; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes, namely, reagents for chemical analyses, reagents for research purposes, chemicals, namely, buffer and standard solutions used in analytical chemistry; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes

Technical research in the field of medicines and technical pharmaceuticals research; technical project studies, namely, conducting of technical feasibility studies in field of medicines and pharmaceuticals; research and development of new products for others; research in the field of environmental protection; scientific laboratory services; product quality testing; chemist services; chemical research; bacteriological research; biological research
cell plaza

General Information


Serial Number79129103
Word MarkCELL PLAZA
Filing DateFriday, December 21, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, December 21, 2022
Registration Number4416595
Registration DateTuesday, October 15, 2013
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 30, 2013

Trademark Statements


Description of MarkThe mark consists of the stylized wording "CELL PLAZA".
Goods and ServicesMedicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; bacterial and bacteriological preparations for medical or veterinary purposes; pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; stem cells for medical purposes; biological tissue cultures for medical purposes; biochemical medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietary and nutritional supplements for medical use
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProtein in raw material form for scientific and medical research; enzymes for the brewing industry; enzymes for use in the textile industry; enzymes for use in the dairy industry; enzymes for use in the food industry; stain repellents for textiles; industrial chemicals; biochemical catalysts; chemical preparations for scientific purposes; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes, namely, reagents for chemical analyses, reagents for research purposes, chemicals, namely, buffer and standard solutions used in analytical chemistry; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes
Disclaimer with Predetermined Text"CELL"
Goods and ServicesTechnical research in the field of medicines and technical pharmaceuticals research; technical project studies, namely, conducting of technical feasibility studies in field of medicines and pharmaceuticals; research and development of new products for others; research in the field of environmental protection; scientific laboratory services; product quality testing; chemist services; chemical research; bacteriological research; biological research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenloci Biotechnologies Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameGenloci Biotechnologies Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameGenloci Biotechnologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Thursday, July 20, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, July 20, 2023DEATH OF INTERNATIONAL REGISTRATION
Sunday, March 6, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 11, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, February 10, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Sunday, February 2, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 16, 2014FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 16, 2014FINAL DISPOSITION PROCESSED
Wednesday, January 15, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 15, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, July 30, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 10, 2013NOTICE OF PUBLICATION
Tuesday, June 25, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 25, 2013ASSIGNED TO LIE
Friday, June 7, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 6, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 5, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 5, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 5, 2013REFUSAL PROCESSED BY IB
Saturday, May 18, 2013APPLICATION FILING RECEIPT MAILED
Thursday, May 16, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 16, 2013REFUSAL PROCESSED BY MPU
Thursday, May 16, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 15, 2013NON-FINAL ACTION WRITTEN
Tuesday, May 14, 2013ASSIGNED TO EXAMINER
Tuesday, May 14, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 13, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, May 9, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB